Alstrom syndrome screening: Difference between revisions

Jump to navigation Jump to search
Raviteja Reddy Guddeti (talk | contribs)
Raviteja Reddy Guddeti (talk | contribs)
Line 5: Line 5:
==Screening==
==Screening==
* Fasting glucose levels are evaluated every two to three months. Closer follow-up is needed if fasting or postprandial blood glucose concentrations are elevated.  
* Fasting glucose levels are evaluated every two to three months. Closer follow-up is needed if fasting or postprandial blood glucose concentrations are elevated.  
 
* Urinalysis and plasma concentrations of electrolytes, uric acid, BUN, and creatinine should be estimated twice-yearly.
 
 
* Twice-yearly urinalysis and plasma concentrations of electrolytes, uric acid, BUN, and creatinine.  
* Annual assessment of vision and hearing; weight, height, and body mass index; heart (including echocardiography); plasma insulin concentration; lipid profile; plasma ALT, AST, and GGT concentrations; pulmonary function; thyroid function.  
* Annual assessment of vision and hearing; weight, height, and body mass index; heart (including echocardiography); plasma insulin concentration; lipid profile; plasma ALT, AST, and GGT concentrations; pulmonary function; thyroid function.  
* Every one to two years, renal and bladder ultrasound examinations if symptomatic and/or if urinalysis is abnormal.
* Renal and bladder ultrasound examinations should be conducted if symptomatic and/or if urinalysis is abnormal, every one to two years.


==References==
==References==

Revision as of 14:35, 22 February 2013

Alstrom syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Differentiating Alstrom syndrome from other Diseases

Epidemiology and Demographics

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Tertiary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Alstrom syndrome screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Alstrom syndrome screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Alstrom syndrome screening

CDC on Alstrom syndrome screening

Alstrom syndrome screening in the news

Blogs on Alstrom syndrome screening

Directions to Hospitals Treating Alstrom syndrome

Risk calculators and risk factors for Alstrom syndrome screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]; Raviteja Guddeti, M.B.B.S. [3]

Screening

  • Fasting glucose levels are evaluated every two to three months. Closer follow-up is needed if fasting or postprandial blood glucose concentrations are elevated.
  • Urinalysis and plasma concentrations of electrolytes, uric acid, BUN, and creatinine should be estimated twice-yearly.
  • Annual assessment of vision and hearing; weight, height, and body mass index; heart (including echocardiography); plasma insulin concentration; lipid profile; plasma ALT, AST, and GGT concentrations; pulmonary function; thyroid function.
  • Renal and bladder ultrasound examinations should be conducted if symptomatic and/or if urinalysis is abnormal, every one to two years.

References


Template:WikiDoc Sources